Special Meeting of Shareholders
Lexaria Bioscience Corp.'s patented drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 36 patents granted and many patents pending worldwide.
#100-740 McCurdy Road
Kelowna, BC V1X 2P7
2226 W. Northern Avenue
Phoenix, AZ 85021
T: 250-765-6424 ext. 202
Computershare Investor Services Inc.